Literature DB >> 7371711

Effects of pirmenol HCl on electrophysiologic properties of cardiac Purkinje fibers.

R F Reder, P Danilo, M R Rosen.   

Abstract

We studied the effects of pirmenol hydrochloride (CI 845), cis-(+/-)-alpha-[3-(2,6-dimethyl-1-piperidinyl)propyl]-alpha-phenyl-2-pyridinemethanol monohydrochloride, on the electrophysiologic properties of canine cardiac Purkinje fibers having normal (fast response) action potentials. CI 845 greater than or equal to 1 X 10(-6) M depressed both maximum upstroke velocity of phase 0 and automaticity. CI 845 greater than or equal to 1 X 10(-5) M significantly decreased action potential amplitude and duration measured at 50% repolarization and prolonged action potential duration measured at full repolarization. In addition, this concentration depressed membrane responsiveness and prolonged the effective refractory period and conduction time. All changes were reversible following superfusion with drug-free Tyrode solution. Increasing extracellular potassium ([K+]0) from 4 mM to 6 mM did not potentiate the CI 845-induced changes. CI 845 1 X 10(-5) M decreased automaticity of slow response action potentials studied in a Na+-free solution but had no effect on the action potential characteristics of these spontaneously discharging fibers. In blood superfusion studies, plasma levels of 0.1--3.0 micrograms/ml CI 845 affected the action potential characteristics in a manner similar to concentrations ranging from 1 X 10(-6) to 1 X 10(-5) M CI 845 in Tyrode solution. At plasma levels greater than or equal to 1.1 micrograms/ml, CI 845 induced a significant prolongation of the electrocardiographic PR interval. These studies indicate that CI 845 has effects on the action potential and ECG similar but not identical to those of 'local anesthetic' antiarrhythmic agents.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7371711     DOI: 10.1016/0014-2999(80)90071-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  Electrophysiologic and anticholinergic effects of pirmenol enantiomers in guinea-pig myocardium.

Authors:  H Nakaya; Y Hattori; M Endou; S Gandou; M Kanno
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-11       Impact factor: 3.000

2.  Salivary concentrations of pirmenol as a possible cause of unpleasant taste.

Authors:  B F Johnson; V Shekar; T Woodman; A T Canada
Journal:  Br J Clin Pharmacol       Date:  1986-11       Impact factor: 4.335

3.  Pirmenol, a new antiarrhythmic drug with potassium- and sodium-channel blocking activity; a voltage-clamp study in rabbit Purkinje fibres.

Authors:  B Reichardt; G Konzen; O Hauswirth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-05       Impact factor: 3.000

4.  Initial and long-term outpatient experience with pirmenol for control of ventricular arrhythmias.

Authors:  E M Hampton; J L Anderson; J R Lutz; J M Nappi
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

5.  Use-dependent effects of pirmenol on Vmax and conduction in guinea-pig ventricular myocardium.

Authors:  J Hasegawa; S Hirai; N Noguchi; I Hisatome; H Kotake; H Mashiba
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

6.  Antiarrhythmic drugs, clofilium and cibenzoline are potent inhibitors of glibenclamide-sensitive K+ currents in Xenopus oocytes.

Authors:  H Sakuta; K Okamoto; Y Watanabe
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

7.  Conversion of paroxysmal atrial fibrillation to sinus rhythm by intravenous pirmenol. A placebo controlled study.

Authors:  L K Toivonen; M S Nieminen; V Manninen; M H Frick
Journal:  Br Heart J       Date:  1986-02

Review 8.  New antiarrhythmic drugs.

Authors:  P F Nestico; J Morganroth; L N Horowitz
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.